|
1
|
Bouhassira D and Attal N: Translational
neuropathic pain research: A clinical perspective. Neuroscience.
338:27–35. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gierthmuhlen J and Baron R: Neuropathic
pain. Semin Neurol. 36:462–468. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Scholz J, Finnerup NB, Attal N, Aziz Q,
Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, et
al: The IASP classification of chronic pain for ICD-11: Chronic
neuropathic pain. Pain. 160:53–59. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Colloca L, Ludman T, Bouhassira D, Baron
R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N,
Finnerup NB, et al: Neuropathic pain. Nat Rev Dis Primers.
3(17002)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gilron I, Baron R and Jensen T:
Neuropathic pain: Principles of diagnosis and treatment. Mayo Clin
Proc. 90:532–545. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Weerink MAS, Struys MMRF, Hannivoort LN,
Barends CRM, Absalom AR and Colin P: Clinical pharmacokinetics and
pharmacodynamics of dexmedetomidine. Clin Pharmacokinet.
56:893–913. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Keating GM: Dexmedetomidine: A review of
its use for sedation in the intensive care setting. Drugs.
75:1119–1130. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jessen Lundorf L, Korvenius Nedergaard H
and Moller AM: Perioperative dexmedetomidine for acute pain after
abdominal surgery in adults. Cochrane Database Syst Rev.
2(CD010358)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lin JP, Chen CQ, Huang LE, Li NN, Yang Y,
Zhu SM and Yao YX: Dexmedetomidine attenuates neuropathic pain by
inhibiting P2X7R expression and ERK phosphorylation in rats. Exp
Neurobiol. 27:267–276. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao Y, He J, Yu N, Jia C and Wang S:
Mechanisms of dexmedetomidine in neuropathic pain. Front Neurosci.
14(330)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jo EK, Kim JK, Shin DM and Sasakawa C:
Molecular mechanisms regulating NLRP3 inflammasome activation. Cell
Mol Immunol. 13:148–159. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
He Y, Hara H and Nunez G: Mechanism and
regulation of NLRP3 inflammasome activation. Trends Biochem Sci.
41:1012–1021. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Coll RC, Robertson AA, Chae JJ, Higgins
SC, Munoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG,
Stutz A, et al: A small-molecule inhibitor of the NLRP3
inflammasome for the treatment of inflammatory diseases. Nat Med.
21:248–255. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Grace PM, Strand KA, Galer EL, Urban DJ,
Wang X, Baratta MV, Fabisiak TJ, Anderson ND, Cheng K, Greene LI,
et al: Morphine paradoxically prolongs neuropathic pain in rats by
amplifying spinal NLRP3 inflammasome activation. Proc Natl Acad Sci
USA. 113:E3441–E3450. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ming T, Yuan M, Kong Q, Huang Q, Xia Z and
Wu X: Dexmedetomidine alleviates blunt chest trauma and hemorrhagic
shock-resuscitation-induced acute lung injury through inhibiting
the NLRP3 inflammasome. Mol Med Rep. 22:2507–2515. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yang T, Feng X, Zhao Y, Zhang H, Cui H,
Wei M, Yang H and Fan H: Dexmedetomidine enhances autophagy via
α2-AR/AMPK/mTOR pathway to inhibit the activation of NLRP3
inflammasome and subsequently alleviates lipopolysaccharide-induced
acute kidney injury. Front Pharmacol. 11(790)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ahmed SM, Luo L, Namani A, Wang XJ and
Tang X: Nrf2 signaling pathway: Pivotal roles in inflammation.
Biochim Biophys Acta Mol Basis Dis. 1863:585–597. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Thimmulappa RK, Lee H, Rangasamy T, Reddy
SP, Yamamoto M, Kensler TW and Biswal S: Nrf2 is a critical
regulator of the innate immune response and survival during
experimental sepsis. J Clin Invest. 116:984–995. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Arruri V, Komirishetty P, Areti A,
Dungavath SK and Kumar A: Nrf2 and NF-κB modulation by Plumbagin
attenuates functional, behavioural and biochemical deficits in rat
model of neuropathic pain. Pharmacol Rep. 69:625–632.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Du L, Wang J, Chen Y, Li X, Wang L, Li Y,
Jin X, Gu X, Hao M, Zhu X, et al: Novel biphenyl diester derivative
AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in
diabetic nephropathy. Cell Biol Toxicol. 36:243–260.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li F, Wang X, Zhang Z, Zhang X and Gao P:
Dexmedetomidine attenuates neuroinflammatory-induced apoptosis
after traumatic brain injury via Nrf2 signaling pathway. Ann Clin
Transl Neurol. 6:1825–1835. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG: NC3Rs Reporting Guidelines Working Group. Animal
research: Reporting in vivo experiments: The ARRIVE guidelines. J
Gene Med. 12:561–563. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wiesenfeld-Hallin Z: Sex differences in
pain perception. Gend Med. 2:137–145. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cruccu G and Truini A: A review of
neuropathic pain: From guidelines to clinical practice. Pain Ther.
6 (Suppl 1):S35–S42. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Attal N and Bouhassira D: Pharmacotherapy
of neuropathic pain: Which drugs, which treatment algorithms? Pain.
156 (Suppl 1):S104–S114. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lees JG, Fivelman B, Duffy SS, Makker PG,
Perera CJ and Moalem-Taylor G: Cytokines in neuropathic pain and
associated depression. Mod Trends Pharmacopsychiatry. 30:51–66.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liang F, Liu M, Fu X, Zhou X, Chen P and
Han F: Dexmedetomidine attenuates neuropathic pain in chronic
constriction injury by suppressing NR2B, NF-κB, and iNOS
activation. Saudi Pharm J. 25:649–654. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Farghaly HS, Mahmoud AM and Abdel-Sater
KA: Effect of dexmedetomidine and cold stress in a rat model of
neuropathic pain: Role of interleukin-6 and tumor necrosis
factor-α. Eur J Pharmacol. 776:139–145. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xie XJ, Ma LG, Xi K, Fan DM, Li JG, Zhang
Q and Zhang W: Effects of microRNA-223 on morphine analgesic
tolerance by targeting NLRP3 in a rat model of neuropathic pain.
Mol Pain. 13(1744806917706582)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tonkin RS, Bowles C, Perera CJ, Keating
BA, Makker PG, Duffy SS, Lees JG, Tran C, Don AS, Fath T, et al:
Attenuation of mechanical pain hypersensitivity by treatment with
Peptide5, a connexin-43 mimetic peptide, involves inhibition of
NLRP3 inflammasome in nerve-injured mice. Exp Neurol. 300:1–12.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jia M, Wu C, Gao F, Xiang H, Sun N, Peng
P, Li J, Yuan X, Li H, Meng X, et al: Activation of NLRP3
inflammasome in peripheral nerve contributes to paclitaxel-induced
neuropathic pain. Mol Pain. 13(1744806917719804)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li S, Yang C, Fang X, Zhan G, Huang N, Gao
J, Xu H, Hashimoto K and Luo A: Role of Keap1-Nrf2 signaling in
anhedonia symptoms in a rat model of chronic neuropathic pain:
Improvement with sulforaphane. Front Pharmacol.
9(887)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yang Y, Luo L, Cai X, Fang Y, Wang J, Chen
G, Yang J, Zhou Q, Sun X, Cheng X, et al: Nrf2 inhibits
oxaliplatin-induced peripheral neuropathy via protection of
mitochondrial function. Free Radic Biol Med. 120:13–24.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tian R, Yang W, Xue Q, Gao L, Huo J, Ren D
and Chen X: Rutin ameliorates diabetic neuropathy by lowering
plasma glucose and decreasing oxidative stress via Nrf2 signaling
pathway in rats. Eur J Pharmacol. 771:84–92. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Pan CW, Pan ZZ, Hu JJ, Chen WL, Zhou GY,
Lin W, Jin LX and Xu CL: Mangiferin alleviates lipopolysaccharide
and D-galactosamine-induced acute liver injury by activating the
Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Eur J
Pharmacol. 770:85–91. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu X, Zhou W, Zhang X, Lu P, Du Q, Tao L,
Ding Y, Wang Y and Hu R: Dimethyl fumarate ameliorates dextran
sulfate sodium-induced murine experimental colitis by activating
Nrf2 and suppressing NLRP3 inflammasome activation. Biochem
Pharmacol. 112:37–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dong Z, Shang H, Chen YQ, Pan LL, Bhatia M
and Sun J: Sulforaphane protects pancreatic acinar cell injury by
modulating Nrf2-Mediated oxidative stress and NLRP3 inflammatory
pathway. Oxid Med Cell Longev. 2016(7864150)2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Castejon ML, Sanchez-Hidalgo M,
Aparicio-Soto M, Montoya T, Martin-LaCave I, Fernandez-Bolanos JG
and Alarcon-de-la-Lastra C: Dietary oleuropein and its new
acyl-derivate attenuate murine lupus nephritis through HO-1/Nrf2
activation and suppressing JAK/STAT, NF-κB, MAPK and NLRP3
inflammasome signaling pathways. J Nutr Biochem.
74(108229)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhang W, Yu T, Cui X, Yu H and Li X:
Analgesic effect of dexmedetomidine in rats after chronic
constriction injury by mediating microRNA-101 expression and the
E2F2-TLR4-NF-κB axis. Exp Physiol. 105:1588–1597. 2020.PubMed/NCBI View Article : Google Scholar
|
